09:30 EDT Catalyst Biosciences Inc trading halted, volatility trading pause
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GYRE:
- Gyre Therapeutics 2.22M share Spot Secondary priced at $9.00
- Closing Bell Movers: Deckers falls 15% on weak guidance; Nuclear names rally
- Gyre Therapeutics Achieves Key Milestone in Phase 3 Trial
- Gyre Therapeutics announces Hydronidone trial met primary endpoint
- Gyre Therapeutics announces common stock offering, no amount given